NCT00225225View on ClinicalTrials.gov

Rosiglitazone-Induced Weight Gain

NATerminatedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone

BEHAVIORAL

dietary recommendation for weight maintenance

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stanford University

OTHER